These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11443938)

  • 21. [Identification of individual antigenic epitopes of the envelope protein in the tick-borne encephalitis virus using monoclonal antibodies].
    Karavanov AS; Matveev LE; Rubin GG; Semashko IV; Tsekhanovskaia NA; Pressman EK
    Vopr Virusol; 1990; 35(2):140-3. PubMed ID: 1697130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis.
    Heinz FX; Allison SL; Stiasny K; Schalich J; Holzmann H; Mandl CW; Kunz C
    Vaccine; 1995 Dec; 13(17):1636-42. PubMed ID: 8719513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of a new member of the TBE flavivirus subgroup by its immunological, pathogenetic and molecular characteristics: identification of subgroup-specific pentapeptides.
    Gao GF; Hussain MH; Reid HW; Gould EA
    Virus Res; 1993 Nov; 30(2):129-44. PubMed ID: 8249442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev.
    Mandl CW; Iacono-Connors L; Wallner G; Holzmann H; Kunz C; Heinz FX
    Virology; 1991 Dec; 185(2):891-5. PubMed ID: 1720591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric antibodies against tick-borne encephalitis virus.
    Levanov LN; Matveev LE; Goncharova EP; Lebedev LR; Ryzhikov AB; Yun TE; Batanova TA; Shvalov AN; Baykov IK; Shingarova LN; Kirpichnikov MP; Tikunova NV
    Vaccine; 2010 Jul; 28(32):5265-71. PubMed ID: 20538092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.
    Kanai R; Kar K; Anthony K; Gould LH; Ledizet M; Fikrig E; Marasco WA; Koski RA; Modis Y
    J Virol; 2006 Nov; 80(22):11000-8. PubMed ID: 16943291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of tick-borne encephalitis virus glycoprotein fragments: epitope-specific analysis of the antibody response.
    Heinz FX; Tuma W; Guirakhoo F; Berger R; Kunz C
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1921-9. PubMed ID: 6209362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization.
    Heinz FX; Mandl CW; Holzmann H; Kunz C; Harris BA; Rey F; Harrison SC
    J Virol; 1991 Oct; 65(10):5579-83. PubMed ID: 1716695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of monoclonal antibodies against Hokkaido strain tick-borne encephalitis virus.
    Komoro K; Hayasaka D; Mizutani T; Kariwa H; Takashima I
    Microbiol Immunol; 2000; 44(6):533-6. PubMed ID: 10941938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
    Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT
    Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative analysis of proteins from persistent and antigen-defective strains of tick-borne encephalitis virus].
    Pressman EK; Malenko GV; Pogodina VV; Matveeva VA; Bochkova NG; Levina LS
    Vopr Virusol; 1997; 42(2):53-6. PubMed ID: 9182398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.
    Rey FA; Heinz FX; Mandl C; Kunz C; Harrison SC
    Nature; 1995 May; 375(6529):291-8. PubMed ID: 7753193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.
    Heinz FX; Stiasny K; Püschner-Auer G; Holzmann H; Allison SL; Mandl CW; Kunz C
    Virology; 1994 Jan; 198(1):109-17. PubMed ID: 8259646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses.
    Trujillo JD; Kumpula-McWhirter NM; Hötzel KJ; Gonzalez M; Cheevers WP
    J Virol; 2004 Sep; 78(17):9190-202. PubMed ID: 15308714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for antigenic stability of tick-borne encephalitis virus by the analysis of natural isolates.
    Guirakhoo F; Radda AC; Heinz FX; Kunz C
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():859-64. PubMed ID: 3029309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody.
    Iacono-Connors LC; Smith JF; Ksiazek TG; Kelley CL; Schmaljohn CS
    Virus Res; 1996 Aug; 43(2):125-36. PubMed ID: 8864202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody.
    Roehrig JT; Hunt AR; Johnson AJ; Hawkes RA
    Virology; 1989 Jul; 171(1):49-60. PubMed ID: 2472704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.